Home
News
Create
Screeners
Insights
Anlon Healthcare
157.
42
-8.29
(-5.00%)
Market Cap
₹836.71 Cr
PE Ratio
39.94
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-5.00%
1M
+16.62%
6M
+71.61%
1Y
+71.61%
5Y
+71.61%
View Company Insights
Latest news about Anlon Healthcare
Anlon Healthcare Acquires Majority Stake in Apiqo Organics for Rs 5.40 Crore
3 hours ago
Today
Anlon Healthcare Limited has entered into a Share Purchase Agreement to acquire a 67.48% stake in Apiqo Organics Private Limited for Rs 5.40 crore. The acquisition involves 55,33,500 equity shares at Rs 9.76 per share. This strategic move aims to enhance Anlon's vertical integration, add 700-800 MT of annual manufacturing capacity for advanced pharmaceutical intermediates, secure critical supply, and strengthen its market position. Apiqo Organics, formerly M/s Apple Life Science, manufactures pharmaceutical intermediates and chemicals. The transaction is expected to close within three months, subject to conditions.
Anlon Healthcare Showcases Global Reach and Growth in Q2/H1 FY26 Investor Presentation
Nov 19, 2025
Anlon Healthcare Reports Strong Q2 FY26 Results, Plans Capacity Expansion
Nov 11, 2025
Neomile Asset Managers Reduces Stake in Anlon Healthcare Through Open Market Sale
Nov 06, 2025
Anlon Healthcare Unveils Two New Anti-Malarial Products for November 2025 Launch
Sep 20, 2025
More news about Anlon Healthcare
15
Sept 25
Anlon Healthcare Limited Reports Shareholding Change Following Equity Share Acquisition
Anlon Healthcare Limited has disclosed a substantial change in its shareholding structure following an acquisition of equity shares. The company has notified both BSE and NSE about this change, complying with SEBI regulations. The disclosure was made on September 13, as per LODR data, and was signed by Managing Director Punitkumar Rasadia. While specific details of the shareholding change were not provided, such disclosures typically indicate a substantial acquisition or change in company ownership.
Anlon Healthcare
157.
42
-
8.
29
(-
5.
00
%)
1 Year Returns:
+71.61%
Industry Peers
Sun Pharmaceutical
1,799.50
(-
0.
44
%)
Divis Laboratories
6,417.50
(-
0.
08
%)
Torrent Pharmaceuticals
3,728.00
(-
0.
24
%)
Cipla
1,516.60
(-
0.
43
%)
Dr Reddys Laboratories
1,275.20
(+
1.
20
%)
Lupin
2,082.70
(+
0.
04
%)
Zydus Life Science
942.70
(+
0.
67
%)
Mankind Pharma
2,216.40
(-
0.
60
%)
Aurobindo Pharma
1,215.20
(-
0.
08
%)
Alkem Laboratories
5,638.50
(+
0.
52
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation